APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medication

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Medication Market Analysis and Forecast 2026-2032

22 December 2025207 pages

Choose your research edition.

Industry ResearchMedication Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Medication Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medication Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Medication Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Medication include Takeda, Teva, Sanofi, Johnson & Johnson, Novartis, Novo Nordisk, Roche, Eli Lilly and Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Medication, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Medication, also provides the revenue of main regions and countries. Of the upcoming market potential for Medication, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medication revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medication revenue, projected growth trends, production technology, application and end-user industry.

Medication Segment by Company

Takeda

Teva

Sanofi

Johnson & Johnson

Novartis

Novo Nordisk

Roche

Eli Lilly

Pfizer

GlaxoSmithKline (GSK)

Bayer

Amgen

AbbVie

AbbVie

AstraZeneca

Merck & Co. (MSD)

Gilead Sciences

Bristol-Myers Squibb

Boehringer Ingelheim

Medication Segment by Type

Brand Drugs

Generic Drug

Medication Segment by Application

Hospital

Clinic

Other

Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Medication in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Medication company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medication revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Brand Drugs Major Player Table 3. Generic Drug Major Player Table 4. Global Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Other Major Player Table 8. Medication Industry Trends Table 9. Medication Industry Drivers Table 10. Medication Industry Opportunities and Challenges Table 11. Medication Industry Restraints Table 12. Global Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Medication Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Medication Market Share by Region (2021-2026) Table 15. Global Medication Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Medication Market Share by Region (2027-2032) Table 17. Global Medication Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Medication Revenue Market Share by Players (2021-2026) Table 19. Global Medication Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Medication Key Players Headquarters & Area Served Table 21. Global Medication Players, Product Type & Application Table 22. Global Medication Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Medication by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Medication Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medication Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Medication Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Medication Revenue Market Share by Type (2021-2026) Table 29. Global Medication Revenue Market Share by Type (2027-2032) Table 30. Global Medication Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Medication Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Medication Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Medication Revenue Market Share by Application (2021-2026) Table 34. Global Medication Revenue Market Share by Application (2027-2032) Table 35. Takeda Company Information Table 36. Takeda Business Overview Table 37. Takeda Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Medication Product Portfolio Table 39. Takeda Recent Development Table 40. Teva Company Information Table 41. Teva Business Overview Table 42. Teva Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Teva Medication Product Portfolio Table 44. Teva Recent Development Table 45. Sanofi Company Information Table 46. Sanofi Business Overview Table 47. Sanofi Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Sanofi Medication Product Portfolio Table 49. Sanofi Recent Development Table 50. Johnson & Johnson Company Information Table 51. Johnson & Johnson Business Overview Table 52. Johnson & Johnson Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Johnson & Johnson Medication Product Portfolio Table 54. Johnson & Johnson Recent Development Table 55. Novartis Company Information Table 56. Novartis Business Overview Table 57. Novartis Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Novartis Medication Product Portfolio Table 59. Novartis Recent Development Table 60. Novo Nordisk Company Information Table 61. Novo Nordisk Business Overview Table 62. Novo Nordisk Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Novo Nordisk Medication Product Portfolio Table 64. Novo Nordisk Recent Development Table 65. Roche Company Information Table 66. Roche Business Overview Table 67. Roche Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Roche Medication Product Portfolio Table 69. Roche Recent Development Table 70. Eli Lilly Company Information Table 71. Eli Lilly Business Overview Table 72. Eli Lilly Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Eli Lilly Medication Product Portfolio Table 74. Eli Lilly Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Pfizer Medication Product Portfolio Table 79. Pfizer Recent Development Table 80. GlaxoSmithKline (GSK) Company Information Table 81. GlaxoSmithKline (GSK) Business Overview Table 82. GlaxoSmithKline (GSK) Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. GlaxoSmithKline (GSK) Medication Product Portfolio Table 84. GlaxoSmithKline (GSK) Recent Development Table 85. Bayer Company Information Table 86. Bayer Business Overview Table 87. Bayer Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Bayer Medication Product Portfolio Table 89. Bayer Recent Development Table 90. Amgen Company Information Table 91. Amgen Business Overview Table 92. Amgen Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Amgen Medication Product Portfolio Table 94. Amgen Recent Development Table 95. AbbVie Company Information Table 96. AbbVie Business Overview Table 97. AbbVie Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. AbbVie Medication Product Portfolio Table 99. AbbVie Recent Development Table 100. AbbVie Company Information Table 101. AbbVie Business Overview Table 102. AbbVie Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. AbbVie Medication Product Portfolio Table 104. AbbVie Recent Development Table 105. AstraZeneca Company Information Table 106. AstraZeneca Business Overview Table 107. AstraZeneca Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. AstraZeneca Medication Product Portfolio Table 109. AstraZeneca Recent Development Table 110. Merck & Co. (MSD) Company Information Table 111. Merck & Co. (MSD) Business Overview Table 112. Merck & Co. (MSD) Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Merck & Co. (MSD) Medication Product Portfolio Table 114. Merck & Co. (MSD) Recent Development Table 115. Gilead Sciences Company Information Table 116. Gilead Sciences Business Overview Table 117. Gilead Sciences Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Gilead Sciences Medication Product Portfolio Table 119. Gilead Sciences Recent Development Table 120. Bristol-Myers Squibb Company Information Table 121. Bristol-Myers Squibb Business Overview Table 122. Bristol-Myers Squibb Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Bristol-Myers Squibb Medication Product Portfolio Table 124. Bristol-Myers Squibb Recent Development Table 125. Boehringer Ingelheim Company Information Table 126. Boehringer Ingelheim Business Overview Table 127. Boehringer Ingelheim Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Boehringer Ingelheim Medication Product Portfolio Table 129. Boehringer Ingelheim Recent Development Table 130. North America Medication Revenue by Type (2021-2026) & (US$ Million) Table 131. North America Medication Revenue by Type (2027-2032) & (US$ Million) Table 132. North America Medication Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Medication Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Medication Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Medication Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Medication Revenue by Country (US$ Million) & (2027-2032) Table 137. Europe Medication Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Medication Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Medication Revenue by Application (2021-2026) & (US$ Million) Table 140. Europe Medication Revenue by Application (2027-2032) & (US$ Million) Table 141. Europe Medication Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Medication Revenue by Country (2021-2026) & (US$ Million) Table 143. Europe Medication Revenue by Country (US$ Million) & (2027-2032) Table 144. China Medication Revenue by Type (2021-2026) & (US$ Million) Table 145. China Medication Revenue by Type (2027-2032) & (US$ Million) Table 146. China Medication Revenue by Application (2021-2026) & (US$ Million) Table 147. China Medication Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia Medication Revenue by Type (2021-2026) & (US$ Million) Table 149. Asia Medication Revenue by Type (2027-2032) & (US$ Million) Table 150. Asia Medication Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Medication Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Medication Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Medication Revenue by Region (US$ Million) & (2021-2026) Table 154. Asia Medication Revenue by Region (US$ Million) & (2027-2032) Table 155. SAMEA Medication Revenue by Type (2021-2026) & (US$ Million) Table 156. SAMEA Medication Revenue by Type (2027-2032) & (US$ Million) Table 157. SAMEA Medication Revenue by Application (2021-2026) & (US$ Million) Table 158. SAMEA Medication Revenue by Application (2027-2032) & (US$ Million) Table 159. SAMEA Medication Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. SAMEA Medication Revenue by Country (2021-2026) & (US$ Million) Table 161. SAMEA Medication Revenue by Country (US$ Million) & (2027-2032) Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Medication Image Figure 2. Global Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medication Market Size Share 2021 VS 2025 VS 2032 Figure 4. Brand Drugs Image Figure 5. Generic Drug Image Figure 6. Global Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Medication Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Medication Market Size (US$ Million) & (2021-2032) Figure 12. Global Medication Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Medication Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Medication Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Medication Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Medication Revenue Market Share by Type (2021-2032) Figure 19. Global Medication Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Medication Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Medication Revenue Market Share by Application (2021-2032) Figure 22. North America Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Medication Revenue Share by Type (2021-2032) Figure 24. North America Medication Revenue Share by Application (2021-2032) Figure 25. North America Medication Revenue Share by Country (2021-2032) Figure 26. United States Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Medication Revenue Share by Type (2021-2032) Figure 31. Europe Medication Revenue Share by Application (2021-2032) Figure 32. Europe Medication Revenue Share by Country (2021-2032) Figure 33. Germany Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Medication Revenue Share by Type (2021-2032) Figure 43. China Medication Revenue Share by Application (2021-2032) Figure 44. Asia Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Medication Revenue Share by Type (2021-2032) Figure 46. Asia Medication Revenue Share by Application (2021-2032) Figure 47. Asia Medication Revenue Share by Region (2021-2032) Figure 48. Japan Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Medication Revenue Share by Type (2021-2032) Figure 56. SAMEA Medication Revenue Share by Application (2021-2032) Figure 57. SAMEA Medication Revenue Share by Country (2021-2032) Figure 58. Brazil Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drugs
  • Generic Drug
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Takeda
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Novo Nordisk
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline (GSK)
  • Bayer
  • Amgen
  • AbbVie
  • AbbVie
  • AstraZeneca
  • Merck & Co. (MSD)
  • Gilead Sciences
  • Bristol-Myers Squibb
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Medication Market by Type
  3. 1.2.1 Global Medication Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Brand Drugs
  5. 1.2.3 Generic Drug
  6. 1.3 Medication Market by Application
  7. 1.3.1 Global Medication Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Medication Market Dynamics
  1. 2.1 Medication Industry Trends
  2. 2.2 Medication Industry Drivers
  3. 2.3 Medication Industry Opportunities and Challenges
  4. 2.4 Medication Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Medication Market Perspective (2021-2032)
  2. 3.2 Global Medication Growth Trends by Region
  3. 3.2.1 Global Medication Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Medication Market Size by Region (2021-2026)
  5. 3.2.3 Global Medication Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Medication Revenue by Players
  2. 4.1.1 Global Medication Revenue by Players (2021-2026)
  3. 4.1.2 Global Medication Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Medication Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Medication Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Medication Key Players Headquarters & Area Served
  7. 4.4 Global Medication Players, Product Type & Application
  8. 4.5 Global Medication Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Medication Market CR5 and HHI
  11. 4.6.3 2025 Medication Tier 1, Tier 2, and Tier 3
5 Medication Market Size by Type
  1. 5.1 Global Medication Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Medication Revenue by Type (2021-2032)
  3. 5.3 Global Medication Revenue Market Share by Type (2021-2032)
6 Medication Market Size by Application
  1. 6.1 Global Medication Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Medication Revenue by Application (2021-2032)
  3. 6.3 Global Medication Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Medication Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Medication Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Medication Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Teva Medication Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Medication Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Medication Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Johnson & Johnson
  20. 7.4.1 Johnson & Johnson Company Information
  21. 7.4.2 Johnson & Johnson Business Overview
  22. 7.4.3 Johnson & Johnson Medication Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Johnson & Johnson Medication Product Portfolio
  24. 7.4.5 Johnson & Johnson Recent Developments
  25. 7.5 Novartis
  26. 7.5.1 Novartis Company Information
  27. 7.5.2 Novartis Business Overview
  28. 7.5.3 Novartis Medication Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Medication Product Portfolio
  30. 7.5.5 Novartis Recent Developments
  31. 7.6 Novo Nordisk
  32. 7.6.1 Novo Nordisk Company Information
  33. 7.6.2 Novo Nordisk Business Overview
  34. 7.6.3 Novo Nordisk Medication Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Novo Nordisk Medication Product Portfolio
  36. 7.6.5 Novo Nordisk Recent Developments
  37. 7.7 Roche
  38. 7.7.1 Roche Company Information
  39. 7.7.2 Roche Business Overview
  40. 7.7.3 Roche Medication Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Roche Medication Product Portfolio
  42. 7.7.5 Roche Recent Developments
  43. 7.8 Eli Lilly
  44. 7.8.1 Eli Lilly Company Information
  45. 7.8.2 Eli Lilly Business Overview
  46. 7.8.3 Eli Lilly Medication Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Eli Lilly Medication Product Portfolio
  48. 7.8.5 Eli Lilly Recent Developments
  49. 7.9 Pfizer
  50. 7.9.1 Pfizer Company Information
  51. 7.9.2 Pfizer Business Overview
  52. 7.9.3 Pfizer Medication Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pfizer Medication Product Portfolio
  54. 7.9.5 Pfizer Recent Developments
  55. 7.10 GlaxoSmithKline (GSK)
  56. 7.10.1 GlaxoSmithKline (GSK) Company Information
  57. 7.10.2 GlaxoSmithKline (GSK) Business Overview
  58. 7.10.3 GlaxoSmithKline (GSK) Medication Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GlaxoSmithKline (GSK) Medication Product Portfolio
  60. 7.10.5 GlaxoSmithKline (GSK) Recent Developments
  61. 7.11 Bayer
  62. 7.11.1 Bayer Company Information
  63. 7.11.2 Bayer Business Overview
  64. 7.11.3 Bayer Medication Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Bayer Medication Product Portfolio
  66. 7.11.5 Bayer Recent Developments
  67. 7.12 Amgen
  68. 7.12.1 Amgen Company Information
  69. 7.12.2 Amgen Business Overview
  70. 7.12.3 Amgen Medication Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Amgen Medication Product Portfolio
  72. 7.12.5 Amgen Recent Developments
  73. 7.13 AbbVie
  74. 7.13.1 AbbVie Company Information
  75. 7.13.2 AbbVie Business Overview
  76. 7.13.3 AbbVie Medication Revenue and Gross Margin (2021-2026)
  77. 7.13.4 AbbVie Medication Product Portfolio
  78. 7.13.5 AbbVie Recent Developments
  79. 7.14 AbbVie
  80. 7.14.1 AbbVie Company Information
  81. 7.14.2 AbbVie Business Overview
  82. 7.14.3 AbbVie Medication Revenue and Gross Margin (2021-2026)
  83. 7.14.4 AbbVie Medication Product Portfolio
  84. 7.14.5 AbbVie Recent Developments
  85. 7.15 AstraZeneca
  86. 7.15.1 AstraZeneca Company Information
  87. 7.15.2 AstraZeneca Business Overview
  88. 7.15.3 AstraZeneca Medication Revenue and Gross Margin (2021-2026)
  89. 7.15.4 AstraZeneca Medication Product Portfolio
  90. 7.15.5 AstraZeneca Recent Developments
  91. 7.16 Merck & Co. (MSD)
  92. 7.16.1 Merck & Co. (MSD) Company Information
  93. 7.16.2 Merck & Co. (MSD) Business Overview
  94. 7.16.3 Merck & Co. (MSD) Medication Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Merck & Co. (MSD) Medication Product Portfolio
  96. 7.16.5 Merck & Co. (MSD) Recent Developments
  97. 7.17 Gilead Sciences
  98. 7.17.1 Gilead Sciences Company Information
  99. 7.17.2 Gilead Sciences Business Overview
  100. 7.17.3 Gilead Sciences Medication Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Gilead Sciences Medication Product Portfolio
  102. 7.17.5 Gilead Sciences Recent Developments
  103. 7.18 Bristol-Myers Squibb
  104. 7.18.1 Bristol-Myers Squibb Company Information
  105. 7.18.2 Bristol-Myers Squibb Business Overview
  106. 7.18.3 Bristol-Myers Squibb Medication Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Bristol-Myers Squibb Medication Product Portfolio
  108. 7.18.5 Bristol-Myers Squibb Recent Developments
  109. 7.19 Boehringer Ingelheim
  110. 7.19.1 Boehringer Ingelheim Company Information
  111. 7.19.2 Boehringer Ingelheim Business Overview
  112. 7.19.3 Boehringer Ingelheim Medication Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Boehringer Ingelheim Medication Product Portfolio
  114. 7.19.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Medication Revenue (2021-2032)
  2. 8.2 North America Medication Revenue by Type (2021-2032)
  3. 8.2.1 North America Medication Revenue by Type (2021-2026)
  4. 8.2.2 North America Medication Revenue by Type (2027-2032)
  5. 8.3 North America Medication Revenue Share by Type (2021-2032)
  6. 8.4 North America Medication Revenue by Application (2021-2032)
  7. 8.4.1 North America Medication Revenue by Application (2021-2026)
  8. 8.4.2 North America Medication Revenue by Application (2027-2032)
  9. 8.5 North America Medication Revenue Share by Application (2021-2032)
  10. 8.6 North America Medication Revenue by Country
  11. 8.6.1 North America Medication Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Medication Revenue by Country (2021-2026)
  13. 8.6.3 North America Medication Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Medication Revenue (2021-2032)
  2. 9.2 Europe Medication Revenue by Type (2021-2032)
  3. 9.2.1 Europe Medication Revenue by Type (2021-2026)
  4. 9.2.2 Europe Medication Revenue by Type (2027-2032)
  5. 9.3 Europe Medication Revenue Share by Type (2021-2032)
  6. 9.4 Europe Medication Revenue by Application (2021-2032)
  7. 9.4.1 Europe Medication Revenue by Application (2021-2026)
  8. 9.4.2 Europe Medication Revenue by Application (2027-2032)
  9. 9.5 Europe Medication Revenue Share by Application (2021-2032)
  10. 9.6 Europe Medication Revenue by Country
  11. 9.6.1 Europe Medication Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Medication Revenue by Country (2021-2026)
  13. 9.6.3 Europe Medication Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Medication Revenue (2021-2032)
  2. 10.2 China Medication Revenue by Type (2021-2032)
  3. 10.2.1 China Medication Revenue by Type (2021-2026)
  4. 10.2.2 China Medication Revenue by Type (2027-2032)
  5. 10.3 China Medication Revenue Share by Type (2021-2032)
  6. 10.4 China Medication Revenue by Application (2021-2032)
  7. 10.4.1 China Medication Revenue by Application (2021-2026)
  8. 10.4.2 China Medication Revenue by Application (2027-2032)
  9. 10.5 China Medication Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Medication Revenue (2021-2032)
  2. 11.2 Asia Medication Revenue by Type (2021-2032)
  3. 11.2.1 Asia Medication Revenue by Type (2021-2026)
  4. 11.2.2 Asia Medication Revenue by Type (2027-2032)
  5. 11.3 Asia Medication Revenue Share by Type (2021-2032)
  6. 11.4 Asia Medication Revenue by Application (2021-2032)
  7. 11.4.1 Asia Medication Revenue by Application (2021-2026)
  8. 11.4.2 Asia Medication Revenue by Application (2027-2032)
  9. 11.5 Asia Medication Revenue Share by Application (2021-2032)
  10. 11.6 Asia Medication Revenue by Country
  11. 11.6.1 Asia Medication Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Medication Revenue by Country (2021-2026)
  13. 11.6.3 Asia Medication Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Medication Revenue (2021-2032)
  2. 12.2 SAMEA Medication Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Medication Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Medication Revenue by Type (2027-2032)
  5. 12.3 SAMEA Medication Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Medication Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Medication Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Medication Revenue by Application (2027-2032)
  9. 12.5 SAMEA Medication Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Medication Revenue by Country
  11. 12.6.1 SAMEA Medication Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Medication Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Medication Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst